Constantin von der Groeben

Editor’s note: The new license allows DEMECAN to increase its annual yield by 2 tons with no specified limit as opposed to increasing its total quantity. Under Germany’s new Medical Cannabis Law (MedCanG), DEMECAN has received a license that allows it to double its production capacity,...

Flora Growth Corp. (NASDAQ:FLGC) has entered into a definitive agreement to acquire all of the issued and outstanding shares of Germany-based TruHC Pharma GmbH. The company’s latest move to further cement its global footprint comes on the heels of a new German cannabis law that went into...

At the Benzinga Cannabis Capital Conference in Hollywood, Florida, Constantin von der Groeben, managing director of Demecan, declared a pivotal moment for global cannabis legislation. ‘We’ve reached a tipping point. I think there’s no stepping back from Germany’s cannabis...

Germany's recent partial legalization of cannabis has shaken up the industry and moved marijuana stocks. Will it have a domino effect on other European countries? How easy it is for the cannabis companies to jump on this opportunity and establish their presence in the German cannabis...

The second most populated country in Europe, Germany, legalized recently marijuana. What does this mean? Even though Germany's cannabis legalization is partial, it significantly impacts the country’s medical marijuana program, and by enabling personal possession, consumption and...